Download PDF
1 / Pages

Other users also viewed these articles

Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia Ismael F. Aomar-Millán; Geoorgette Fatoul-del Pino; Úrsula Torres-Parejo; Laura Pérez Fernández; Silvia Martínez-Diz; Juan Salvatierra;
Med Clin. 2023;160:156-9
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease Haitham M.H. Qutob; Ramadan A. Saad; Hamza Bali; Abdulaziz Osailan; Jumana Jaber; Emad Alzahrani; Jamilah Alyami; Hani Elsayed; Raed Alserihi; Osama A. Shaikhomar;
Med Clin. 2022;159:569-74
Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab Adrián Sánchez-Montalvá; Júlia Sellarés-Nadal; Juan Espinosa-Pereiro; Nuria Fernández-Hidalgo; Santiago Pérez-Hoyos; Fernando Salvador; Xavier Durà; Marta Miarons; Andrés Antón; Simeón Eremiev-Eremiev; Abiu Sempere-González; Arnau Monforte-Pallarés; Pau Bosch-Nicolau; Salvador Augustin; Júlia Sampol; Alfredo Guillén-del-Castillo; Benito Almirante;
Med Clin. 2022;158:509-18